Name: "The complosome – an unexpected central player in cell physiology" Claudia Kemper, PhD, Principal Investigator, Immunology Center, Chief, Complement and Inflammation, Research Section (CIRS) National Heart, Lung, and Blood Institute NIH - 2/24/2026
Start: 2026-02-24T12:00:00
End: 2026-02-24T13:00:00
Location: 170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1)

Feb

24

"The complosome – an unexpected central player in cell physiology" Claudia Kemper, PhD, Principal Investigator, Immunology Center, Chief, Complement and Inflammation, Research Section (CIRS) National Heart, Lung, and Blood Institute NIH

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Mar

03

"Defining protective anti-viral B cell responses" James Kobie, PhD, Associate Professor, Infectious Diseases, The University of Alabama at Birmingham School of Medicine

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Mar

10

"Understanding, Predicting, and Remediating Perturbations to Host-Microbe Interactions" Gautam Dantas, PhD, Conan Professor of Laboratory and Genomic Medicine, Washington University School of Medicine in St Louis

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Mar

24

"Fantastic Antigens and Where to Find Them: Cell Based T Cell Antigen Discovery" Alok Joglekar, PhD Assistant Professor Department of Immunology University of Pittsburgh

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Mar

31

"Inflammation to Arthritis: Immune Suppression by 14-3-3zeta" Ritu Chakravarti, PhD, Associate Professor, Director, Translational Rheumatic Disease Research Program, Internal Medicine & MIMG, Rheumatology, University of Kentucky

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Apr

07

"Reprogramming the Breast Tumor Microenvironment: Insights into Cancer-Immune Signaling and Therapeutic Strategies" Sanjay Mishra, PhD, Research Assistant Professor Ohio State University

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Apr

14

"Development of a vaccine for leishmaniasis: Folk medicine to clinic" Abhay Satoskar, MD, PhD, Professor and Vice Chair, Department of Pathology, Ohio State University

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Apr

21

"Innate immunity: unexpected roles in the anti-tumor response" Pam Ohashi, PhD, FRSC Professor, Department of Immunology Senior Scientist, Princess Margaret Cancer Centre Director, Tumor Immunotherapy Program (TIP)

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

Apr

28

"Epigenetic and Environmental Mechanisms Governing Autoimmune CD4+ T Cell persistence" Maria Bettini, PhD, Professor of Pathology, Microbiology and Immunology University of Utah

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

May

05

"Flare, Fight, or Fix: What Exactly Are Eosinophils Doing during Lung Infection?” Amali Samarasinghe, MS, PhD, ATSF, Associate Professor, Department of Medicine, Division of Allergy Pulmonary and Critical Care, University of Wisconsin-Madison

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

12:00 PM

170 DHLRI (Simulcast PRC 3001, NCH RB2.5.1) - Columbus, OH

1.00 Credit Hour(s)

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

View Details

10 Search Results Found